Orthostatic intolerance in chronic fatigue syndrome.
Garner, Richard, Baraniuk, James N · Journal of translational medicine · 2019 · DOI
Quick Summary
This study looked at dizziness and lightheadedness symptoms in ME/CFS patients when lying down versus standing up. Researchers found that these symptoms were very common in ME/CFS (occurring in 72% of patients when standing) and that they often happened even while lying down—something doctors don't usually check for. Importantly, these symptoms weren't simply caused by a rapid heart rate, suggesting a different mechanism is at play in ME/CFS.
Why It Matters
Orthostatic intolerance significantly impacts quality of life in ME/CFS patients but is often underrecognized. This study reveals that OI symptoms in ME/CFS may operate through mechanisms beyond heart rate acceleration, potentially opening new avenues for diagnosis and treatment. Identifying that recumbent symptoms are common challenges clinicians to reassess how they evaluate and manage OI in this population.
Observed Findings
Dizziness and lightheadedness occurred in 41% of CFS patients while recumbent and 72% while standing, compared to lower rates in controls.
Only 6 CFS subjects met POTS criteria (≥30 bpm heart rate increase) and 10 demonstrated START phenotype (exercise-induced tachycardia).
OI symptoms did not correlate with orthostatic tachycardia, suggesting a dissociation between symptom severity and heart rate response.
Patients stratified into 'Persistent OI' group showed highest symptom severity, symptom lability after exercise, and symptoms in both recumbent and standing positions.
Inferred Conclusions
Recumbent dizziness and lightheadedness are common but underreported in ME/CFS and should be routinely assessed clinically.
Orthostatic intolerance in ME/CFS is largely independent of heart rate-mediated mechanisms, implicating alternative physiological pathways.
ME/CFS patients demonstrate heterogeneous OI phenotypes that warrant stratification for differential diagnosis and targeted management.
Remaining Questions
What physiological mechanisms (blood pressure dysregulation, autonomic dysfunction, cerebral hypoperfusion) underlie OI symptoms when heart rate changes are minimal?
How do Persistent OI and Postural OI phenotypes differ in long-term outcomes, symptom progression, and treatment responses?
What This Study Does Not Prove
This study does not establish causation or the underlying physiological mechanisms driving OI symptoms in ME/CFS. It does not prove that non-tachycardia mechanisms are the primary driver of symptoms, only that tachycardia alone does not account for reported symptoms. As a cross-sectional study, it cannot determine whether OI develops as a consequence of ME/CFS or is an independent comorbidity.